Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (alloHCT) remains a major therapeutic challenge. We studied outcomes of 1788 AML patients relapsing after alloHCT (1990–2010) during first or second complete remission (CR) to identify factors associated with lo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Bejanyan, Nelli, Weisdorf, Daniel J., Logan, Brent R., Wang, Hai-Lin, Devine, Steven M., de Lima, Marcos, Bunjes, Donald W., Zhang, Mei-Jie
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329076/
https://ncbi.nlm.nih.gov/pubmed/25460355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.11.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars